Comparison of ceftazidime degradation in glass bottles and plastic bags under various conditions

Journal of Clinical Pharmacy and Therapeutics

Volumn 27, Issue 3, 2002, Pages 205-209

  Arsene M ^a   Favetta, P ^a   Favier, B ^a   Bureau, J ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Ceftazidime; Degradation; Glass; Polypropylene; Polyvinyl chloride; Pyridine; Sorption

Indexed keywords

CEFTAZIDIME; DILUENT; FORTUMSET; GLUCOSE; POLYPROPYLENE; POLYVINYLCHLORIDE; PYRIDINE; SODIUM CHLORIDE; CEPHALOSPORIN DERIVATIVE; GLASS; PYRIDINE DERIVATIVE;

ADSORPTION; ARTICLE; CONTAINER; DRUG DEGRADATION; DRUG STABILITY; DRUG STORAGE; GLASS BOTTLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STORAGE TEMPERATURE; ANALYSIS OF VARIANCE; CHEMISTRY; DRUG PACKAGING; INTRAVENOUS DRUG ADMINISTRATION; SOLUTION AND SOLUBILITY; TEMPERATURE; TIME;

ANALYSIS OF VARIANCE; CEFTAZIDIME; CEPHALOSPORINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; GLASS; INFUSIONS, INTRAVENOUS; POLYPROPYLENES; POLYVINYL CHLORIDE; PYRIDINES; SOLUTIONS; TEMPERATURE; TIME FACTORS;

EID: 0035987492     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2002.00406.x     Document Type: Article

References (25)

1. Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: Clinical outcome, microbiology and pharmaco-kinetics
2. Health risks posed by use of di-2-ethyl-hexyl phthalate (DEHP) in PVC medical devices: A critical review
3. Interactions between drugs and polyvinyl chloride infusion bags
4. Adsorption of recombinant human granulocyte colony stimulating factor (rhG-CSF) to polyvinyl chloride, polypropylene, and glass: Effect of solvent additives
5. Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-propylene infusion containers
6. Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes
7. Stability, compatibility and plasticizer extraction of quinine injection added to infusion solutions and stored in polyvinyl chloride (PVC) containers
8. Leaching of diethylhexylphthalate from polyvinyl chloride containers by selected drugs and formulation components
9. Stability of ceftazidime in plastic syringes and glass vials under various storage conditions
10. Stability of cefepime hydrochloride injection in polypropylene syringes at -20°C, 4°C, and 22-24°C
11. Simultaneous quantification of ceftazidime and pyridine, its main degradation product, by high-performance liquid chromatography
12. Chemical stabilities of cefoperazone sodium and ceftazidiime in 5% dextrose and 0.9% sodium chloride injections
13. Stability of ceftazidime in a viscous eye drop formulation
14. Kinetic oxymoron: Concentration-dependent first-order rate constants for hydrolysis of ceftazidime
15. Sorption of drugs by plastic infusion bags
16. Determination of ceftazidime and pyridine by HPLC: Application to a viscous eye drop formulation
17. Evaluation of Fortum stability disposable infusion devices by pyridine assay
18. Stability of reconstituted solutions of ceftazidime for injections: An HPLC and CE approach
19. Stability of propafenone hydrochloride in i.v. solutions
20. Stability of cidofovir in 0.9% sodium chloride injection and in 5% dextrose injection
21. Stability of undiluted and diluted adenosine at three temperatures in syringes and bags
22. Stability of lorazepam 1 and 2 mg/mL in glass bottles and polypropylene syringes
23. Stability of somatropin stored in plastic syringes for 28 days
24. Influence of pH, temperature, and buffers on the kinetics of ceftazidime degradation in aqueous solutions